myRAteam

Great question! GLP-1 drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are generating real buzz in the RA world right now.

A recent study looked at people with RA who were also overweight or had obesity. Those taking a GLP-1 drug experienced some encouraging results, including:

- Reduced RA Show Full Answer

Great question! GLP-1 drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are generating real buzz in the RA world right now.

A recent study looked at people with RA who were also overweight or had obesity. Those taking a GLP-1 drug experienced some encouraging results, including:

- Reduced RA disease activity
- Less joint pain
- Lower inflammatory markers (CRP and ESR)
- Improved cholesterol and blood sugar levels

What's particularly interesting is that the improvements in pain and inflammation weren't strongly tied to how much weight was lost. This suggests GLP-1 drugs may be reducing inflammation through other pathways in the body. That said, there are some important things to keep in mind:

- GLP-1 drugs are not currently approved to treat RA specifically
- About one-third of study participants stopped taking them due to side effects like nausea or stomach upset, or due to insurance and cost barriers
- More research, including larger clinical trials, is still needed

If this is something that sparks curiosity, it's worth having a conversation with your rheumatologist or primary care provider to see if a GLP-1 drug might make sense for your overall health picture.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

GLP-1 Drugs May Improve Weight and Inflammation in Rheumatoid Arthritis